Tech Tidbits From Around New Hampshire - NH Business Review
NH Business Review NH companies attract investment and recognition ... and more May 27, 2021 MilliporeSigma’s launches new synthetic cholesterol product, which could be used in mRNA therapeutics, including Pfizer-BioNTech Covid-19 Vaccine. MilliporeSigma has launched a new product nine months ahead of schedule in order to meet what it says is the high demand for lipids, a key component of mRNA-based vaccines and therapeutics. The German manufacturer, which has a location in Jaffrey, NH, is manufacturing the synthetic cholesterol product in Darmstadt, Germany, though it also manufactures lip...
Source: nhbr.com